Applications: Used for the quantitative determination of Trastuzumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 70.12 ng/mL
Range: 78.13 - 5,000 ng/mL
Applications: Used for the quantitative determination of Pertuzumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 26.04 ng/mL
Range: 93.75 - 6,000 ng/mL
Applications: Used for the quantitative determination of Disitamab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 43.24 ng/mL
Range: 62.5 - 4,000 ng/mL
Applications: Used for the quantitative determination of Milatuzumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 107.29 ng/mL
Range: 312.5 - 20,000 ng/mL
Applications: Used for the quantitative determination of Otilimab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 80.29 ng/mL
Range: 125 - 8,000 ng/mL
Applications: Used for the quantitative determination of Namilumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 27.06 ng/mL
Range: 93.75 - 6,000 ng/mL
Applications: Used for the quantitative determination of Lenzilumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 118.12 ng/mL
Range: 234.38 - 15,000 ng/mL
Applications: Used for the quantitative determination of Eldelumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 58.12 ng/mL
Range: 156.25 - 10,000 ng/mL
Applications: Used for the quantitative determination of Zanolimumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 80.12 ng/mL
Range: 156.25 - 10,000 ng/mL
Applications: Used for the quantitative determination of Tregalizumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 22.21 ng/mL
Range: 93.75 - 6,000 ng/mL
